PE-conjugated Anti-DLL3(Rovalpituzumab biosimilar) mAb

Größe

£290.00

SKU:: BME100068P
Zusätzliche Namen:: SC0001-SCX;SC0002;sc0001-SCX
Lagerbedingungen:: Store at 2[o]C-8[o]C for 6 months
Hersteller:: DIMA Biotechnology Ltd
Host:: Human
Reaktivitäten:: Human
Formulierung:: Liquid PBS with 0.05% Proclin300; 1% BSA
Target:: DLL3
Weitere Details:: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.